The global AI-based medical imaging market is expected to increase by USD 8.3 billion, at a compound annual growth rate (CAGR) of 31.6% from 2023 to 2029, according to the latest edition of the Global AI-Based Medical Imaging Market Report.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global AI-based medical imaging market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors' approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the offering, modality, deployment mode, therapeutic application, workflow, end user, and region. The global market for AI-based medical imaging can be segmented by offering: hardware, software. The software segment is estimated to account for the largest share of the global AI-based medical imaging market. AI-based medical imaging market is further segmented by modality: computed tomography (CT), magnetic resonance (MR), mammography, multi-modality imaging systems, ultrasound, x-ray, others. The CT segment held the largest revenue share in 2022. Based on deployment mode, the AI-based medical imaging market is segmented into: cloud-based, on-premises. Globally, the cloud-based segment made up the largest share of the AI-based medical imaging market. On the basis of therapeutic application, the AI-based medical imaging market also can be divided into: general imaging, specialty imaging. The specialty imaging segment was the largest contributor to the global AI-based medical imaging market in 2022. AI-based medical imaging market by workflow is categorized into: detection, diagnosis and treatment decision support, equipment maintenance, image acquisition, image analysis, predictive analysis and risk assessment, reporting and communication, triage. The AI-based medical imaging market by end user can be segmented into: diagnostic imaging centers, hospitals, other. Based on region, the AI-based medical imaging market is further categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.
The specialty imaging market is further segmented into cardiology, neurology, oncology (breast cancer, lung cancer, others), orthopedics, respiratory, others. The oncology segment held the largest share of the global AI-based medical imaging market in 2022, representing more than 93.4% of the total market.
Market Segmentation
By offering: hardware, software
By modality: computed tomography (CT), magnetic resonance (MR), mammography, multi-modality imaging systems, ultrasound, x-ray, others
By deployment mode: cloud-based, on-premises
By therapeutic application: general imaging, specialty imaging
By workflow: detection, diagnosis and treatment decision support, equipment maintenance, image acquisition, image analysis, predictive analysis and risk assessment, reporting and communication, triage
By end user: diagnostic imaging centers, hospitals, other
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The market research report covers the analysis of key stake holders of the global AI-based medical imaging market. Some of the leading players profiled in the report include Agfa-Gevaert N.V., Aidoc Medical Ltd., Arterys Inc., Avicenna.AI SAS, Beijing Infervision Technology Co., Ltd., Blackford Analysis Limited, Butterfly Network, Inc., CellmatiQ GmbH, dentalXrai GmbH, Digital Diagnostics Inc., EchoNous Inc., FUJIFILM Holdings Corporation, GE HealthCare Technologies Inc., Gleamer SAS, HeartVista Inc., Hologic, Inc., Hyperfine, Inc., iCAD Inc., Koninklijke Philips NV, Lunit Inc., Mediaire GmbH, Medo Inc., Merative US L.P. (formerly IBM Watson Health), Mirada Medical Ltd., Nano-X Imaging Ltd. (Zebra Medical Vision, Inc.), Nuance Communications, Inc., Nvidia Corporation, Paige AI, Inc., Perimeter Medical Imaging AI, Inc., Qure.ai Technologies Private Limited, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
• To analyze and forecast the market size of the global AI-based medical imaging market.
• To classify and forecast the global AI-based medical imaging market based on offering, modality, deployment mode, therapeutic application, workflow, end user, region.
• To identify drivers and challenges for the global AI-based medical imaging market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global AI-based medical imaging market.
• To identify and analyze the profile of leading players operating in the global AI-based medical imaging market.
Why Choose This Report
• Gain a reliable outlook of the global AI-based medical imaging market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
PART 5. MARKET BREAKDOWN BY OFFERING
· Hardware
· Software
PART 6. MARKET BREAKDOWN BY MODALITY
· Computed tomography (CT)
· Magnetic resonance (MR)
· Mammography
· Multi-modality imaging systems
· Ultrasound
· X-ray
· Others
PART 7. MARKET BREAKDOWN BY DEPLOYMENT MODE
· Cloud-based
· On-premises
PART 8. MARKET BREAKDOWN BY THERAPEUTIC APPLICATION
· General imaging
· Specialty imaging
PART 9. MARKET BREAKDOWN BY WORKFLOW
· Detection
· Diagnosis and treatment decision support
· Equipment maintenance
· Image acquisition
· Image analysis
· Predictive analysis and risk assessment
· Reporting and communication
· Triage
PART 10. MARKET BREAKDOWN BY END USER
· Diagnostic imaging centers
· Hospitals
· Other
PART 11. MARKET BREAKDOWN BY REGION
· North America
· Europe
· Asia-Pacific
· MEA (Middle East and Africa)
· Latin America
PART 12. KEY COMPANIES
· Agfa-Gevaert N.V.
· Aidoc Medical Ltd.
· Arterys Inc.
· Avicenna.AI SAS
· Beijing Infervision Technology Co., Ltd.
· Blackford Analysis Limited
· Butterfly Network, Inc.
· CellmatiQ GmbH
· dentalXrai GmbH
· Digital Diagnostics Inc.
· EchoNous Inc.
· FUJIFILM Holdings Corporation
· GE HealthCare Technologies Inc.
· Gleamer SAS
· HeartVista Inc.
· Hologic, Inc.
· Hyperfine, Inc.
· iCAD Inc.
· Koninklijke Philips NV
· Lunit Inc.
· Mediaire GmbH
· Medo Inc.
· Merative US L.P. (formerly IBM Watson Health)
· Mirada Medical Ltd.
· Nano-X Imaging Ltd. (Zebra Medical Vision, Inc.)
· Nuance Communications, Inc.
· Nvidia Corporation
· Paige AI, Inc.
· Perimeter Medical Imaging AI, Inc.
· Qure.ai Technologies Private Limited
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
The Comprehensive Medical Cold Chain Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive land...
The Medical Intelligent Speech Recognition System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive ...
In 2018, the local hemostatic market in Korea is estimated to have reached US$*** million based on initial supply price and US$*** million based on end user (medical institution) purchase price.Korean hemostatic market is expected to grow at an average annual rate of ***% over the five year...
As of 2022, the total market size of intraocular lenses in Korea is estimated to be approximately ***units (***USD) by manufacturers'/importers' initial selling unit and ***units (***USD) by medical institutions' purchase unit.
It is estimated that the relatively high production/import volume...
In this report, medical AI is defined as artificial intelligence used across the healthcare industry. AI-enabled medical devices are in particular referred to devices which assist healthcare providers in diagnosing, managing and/or predicting diseases through analyzing medical big data with artifici...
In Korea, Private Health Insurance means private insurance plans introduced to supplement the National Health Insurance Service, the nationwide public health insurance system.
When the insured with illness or injury receive medical treatments such as hospital stay, out-patient care or prescri...
As of 2022, the total market size of the wound dressings in Korea is estimated to be approximately USD *** million, about an increase of ***% compared to the previous year. Reimbursement volume is estimated to be approximately USD *** million - around ***% of the entire market.
Afterwards, it...
In 2022, the total market size of dental implants in Korea is estimated to be approxiamately USD ***million at manufacturers/importers' initial selling prices (about *** units, including fixtures and upper parts) and USD *** million at medical institutions' purchase prices.
The dental implants...
Dermal fillers are classified by the MFDS as Class Ⅳ medical devices, with the product classification number B04230.01 (biomaterial graft/prosthesis) or B04230.02 (graft/prosthesis).
According to the , dermal fillers are non-rei...
In 2022, the total market size of anti-adhesion products in Korea is estimated to be approximately USD *** million (manufacturers/importers' initial selling prices) and USD *** million (medical institutions' purchase prices).
While some estimates put the market size at around USD *** million ...